31
Participants
Start Date
September 27, 2021
Primary Completion Date
August 31, 2025
Study Completion Date
December 31, 2025
AN4005-dose level 0
50mg BID
AN4005-dose level 1
100mg BID
AN4005-dose level 2
200mg BID
AN4005-dose level 3
400mg BID
AN4005-dose level 4
600mg BID
AN4005-food effect
Dose to be determined upon the MTD determination
RECRUITING
Montefiore Einstein Cancer Center, The Bronx
RECRUITING
Next Virginia, Fairfax
RECRUITING
Prisma Health Institute for Translational Oncology Research, Greenville
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
RECRUITING
Hackensack University Medical Center, Hackensack
Adlai Nortye Biopharma Co., Ltd.
INDUSTRY